Last May we had told you about an initiative at the Broad Institute in Cambridge, Massachusetts, designed — initially — to generate a comprehensive database of advanced prostate cancer treatment results based on the genetics of individual patients and their tumors. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: Broad, genomic, Instititute, research, study | 6 Comments »
Many patients newly diagnosed with castration-resistant prostate cancer (CRPC) may be interested in participating in a new registry study known as the TRUMPET study, which has just started to enroll patients and is sponsored by Astellas and Medivation (the developers and marketers of enzalutamide/Xtandi). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: care, patterns, registry, study, trial, TRUMPET | Leave a comment »
An opinion piece in the May 4 issue of the Journal of Clinical Oncology has outlined serious (and not unreasonable) questions about the long-term viability of focal therapy (of any type) as a method for the treatment of small foci of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: focal, risk, study, therapy, trial | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 